A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib.
Indexed inpubmed
Abstract
No abstract available for this paper.
Citation impact
5,948
total citations
- FWCI
- —
- Percentile
- —
- References
- 28
Citations per year
Authors
1Topics & keywords
Topics
Keywords
- Sorafenib
- Medicine
- Hepatocellular carcinoma
- Internal medicine
- Hazard ratio
- Placebo
- Gastroenterology
- Carcinoma
No related works found for this paper.